Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Jacobson DH, Gorman CA. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr Rev 1984: 5: 200-20.

Gorman CA. Ophthalmopathy of Graves' disease. (Editorial.) N Engl J Med 1983; 308: 453-5.

van Dijk HJL. Orbital Graves' disease. A modification of the 'NOSPECS'-classification. Ophthalmology 1981; 88: 479-84.

Brian R. Cortisone in exophthalmos: report on a therapeutic trial of cortisone and corticotrophin (ACTH)) in exophthalmos and exophthalmic ophthalmoplegia by a panel appointed by the Medical Research Council. Lancet 1955; i: 6-9.

Day RM, Caroll FD. Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction. Trans Am Ophthalmol Soc 1967; 65: 41-51.

McCohany WH. The eye and orbit in thyroid disease. New York: Raven Press, 1984: 317-23.

Hurbli T, Char DH, Harris J, Weaver R, Greenspan F, Sheline G. Radiation therapy for thyroid eye disease. Am J Ophthalmol 1985; 99: 633-7.

Sergott RC, Felberg NT, Savino PJ, Blizzard JJ, Schatz NJ. Graves' ophthalmopathy-immunologic parameters related to corticosteroid therapy. Invest Ophthalmnol Vis Sci 1981; 20: 17383.

It) DeSanto LW. Transantral orbital decompression. In: Gormann CA, Wailer RR, Dyer JA, eds. The eye and orbit in thyroid disease. New York: Raven Press, 1984: 236.

Char DH. Eye signs and diagnosis of thyroid ophthalmopathy. In: Gardner J, Vaughn V, Powell L, eds. Thyroid eye disease. Baltimore: Williams and Wilkins, 1985: 37.

Koornneef L. Eyelid and orbital fascial attachments and their clinical significance. Eye 1988: 2: 13(04.

Gilbard JP, Linsy Farrir R. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol (Kb/h) 1983: 61: 108-16.

Prummel MF, Mourits MPh, Wiersinga WM, et al.. Cyclosporine versus prednisone in the treatment of severe Graves' ophthalmopathy. Preliminary results. (Abstr.) In: University of Texas Health Science Center, ed. The second international congress on cyclosporine. Washington DC, 1987: 92.

Werner SC. Classification of the eye changes of Graves' disease. J Clin Endocrinol Metab 1969; 29: 782-4.

Werner SC. Modification o)f the classification-of the eye changes of Graves' disease. Am J Ophthalmol 1977: 83: 725-7.

Frueh BR, Musch DC, Grill R, Garber F, Hamby S. Orbital compliance in Graves' eye disease. Ophthalmology 1985; 92: 657-65.

Kahaly G, Schrezenmeir J, Krause U, et al. Cyclosporine and prednisone.v. prednisone in treatment of Graves' ophthalmopathy, a controlled randomized and prospective study. Eur J of Clin Invest 1986; 16: 415-22.